Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015 May 14;10(5):e0126016.
doi: 10.1371/journal.pone.0126016. eCollection 2015.

Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies

Weifeng Shang  1 , Yong Ning  1 , Xiu Xu  1 , Menglan Li  1 , Shuiming Guo  1 , Min Han  1 , Rui Zeng  1 , Shuwang Ge  1 , Gang Xu  1
Affiliations
Meta-Analysis

Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies

Weifeng Shang et al. PLoS One. .

Abstract

Objective: The purpose of this paper is to examine cancer incidence in patients with ANCA-associated vasculitis (AASV) derived from population-based cohort studies by means of meta-analysis.

Methods: Relevant electronic databases were searched for studies characterizing the associated risk of overall malignancy in patients with AASV. Standardized incidence rates (SIRs) with 95% confidence intervals (CIs) were used to evaluate the strength of association. We tested for publication bias and heterogeneity and stratified for site-specific cancers.

Results: Six studies (n = 2,578) were eventually identified, of which six provided the SIR for overall malignancy, five reported the SIR for non-melanoma skin cancer (NMSC), four for leukemia, five for bladder cancer, three for lymphoma, three for liver cancer, four for lung cancer, three for kidney cancer, four for prostate cancer, four for colon cancer and four for breast cancer. Overall, the pooled SIR of cancer in AASV patients was 1.74 (95%CI = 1.37-2.21), with moderate heterogeneity among these studies (I(2) = 65.8%, P = 0.012). In sub-analyses for site-specific cancers, NMSC, leukemia and bladder cancer were more frequently observed in patients with AASV with SIR of 5.18 (95%CI = 3.47-7.73), 4.89 (95%CI = 2.93-8.16) and 3.84 (95%CI = 2.72-5.42) respectively. There was no significant increase in the risk of kidney cancer (SIR = 2.12, 95%CI = 0.66-6.85), prostate cancer (SIR = 1.45, 95%CI = 0.87-2.42), colon cancer (SIR = 1.26, 95%CI = 0.70-2.27), and breast cancer (SIR = 0.95, 95%CI = 0.50-1.79). Among these site-specific cancers, only NMSC showed moderate heterogeneity (I2 = 55.8%, P = 0.06). No publication bias was found by using the Begg's test and Egger's test.

Conclusions: This meta-analysis shows that AASV patients treatment with cyclophosphamide (CYC) are at increased risk of late-occurring malignancies, particularly of the NMSC, leukemia and bladder cancer. However, there is no significant association between AASV and kidney cancer, prostate cancer, colon cancer and breast cancer. These findings emphasize monitoring and preventative management in AASV patients after cessation of CYC therapy is momentous.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Literature search flow diagram.
Fig 2
Fig 2. Forest plot of association between ANCA-associated vasculitis (AASV) and overall cancer.
See this image and copyright information in PMC

References

    1. Jennette JC, Falk RJ, Hu P Xiao H (2013) Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol 8: 139–160. 10.1146/annurev-pathol-011811-132453 - DOI - PMC - PubMed
    1. Scott DG, Watts RA (2013) Epidemiology and clinical features of systemic vasculitis. Clin Exp Nephrol 17: 607–610. 10.1007/s10157-013-0830-8 - DOI - PubMed
    1. Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98: 76–85 - PubMed
    1. Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, et al. (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70: 488–494. 10.1136/ard.2010.137778 - DOI - PubMed
    1. Keogh KA, Ytterberg SR, Fervenza FC, Carlson KA, Schroeder DR, Specks U (2006) Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 173: 180–187. 10.1164/rccm.200507-1144OC - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources